Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Cognitive Dysfunction 1

Interventions

Surveys and Questionnaires 543 Blood Specimen Collection 446 Surgical Procedures, Operative 164 Observation 152 Drug Therapy 142 Radiotherapy 141 Interviews as Topic 139 Gene Expression Profiling 129 Biopsy 117 Magnetic Resonance Spectroscopy 116 Immunohistochemistry 112 Data Collection 95 Polymerase Chain Reaction 87 Specimen Handling 81 Amplified Fragment Length Polymorphism Analysis 81 Bevacizumab 78 Microarray Analysis 76 Flow Cytometry 69 Neoadjuvant Therapy 68 Watchful Waiting 66 Magnetic Resonance Imaging 65 Immune Checkpoint Inhibitors 61 Nivolumab 60 Immunotherapy 57 Therapeutics 55 Reverse Transcriptase Polymerase Chain Reaction 52 pembrolizumab 50 Ultrasonography 47 Positron Emission Tomography Computed Tomography 47 Hematologic Tests 46

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Climate Anxiety × Clear all

NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡